Utilizing a CDST for Resistant/Refractory CMV in Solid Organ Transplant Patients

Activity Overview

Join Drs. Kotton, Razonable, and Humar as they illustrate how to use a new clinical decision support tool (CDST) for resistant or refractory cytomegalovirus (CMV) infection in solid organ transplant (SOT) patients. They will walk you through a challenging CMV resistant patient case and demonstrate how to enter clinical data into the novel CDST for optimal treatment decision making. An expert panel discussion provides opportunity for you to learn how to apply the CDST in practice and incorporate a new therapy, maribavir, into the care of SOT patients with resistant or refractory CMV infection.

0.50 CE Credit(s)
Expires: August 4, 2022

Target Audience

This activity is intended for transplantation, infectious disease, and nephrology clinicians who manage patients with CMV infection after solid organ transplant.

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Employ clinical decision support tool recommendations and current guidelines for the treatment of refractory cytomegalovirus (CMV) infection after transplantation
  • Identify risk factors for the development of refractory and drug resistant CMV after transplantation
  • Select treatment for refractory and drug resistant CMV after transplantation based on key data for recently approved therapies
  • Manage potential adverse effects associated with antiviral therapies for CMV

Activity Faculty

Camille Kotton portrait 2021

Camille Nelson Kotton, MD, FIDSA, FAST

Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Massachusetts General Hospital
Harvard Medical School
Boston, MA

humar

Atul Humar, MD, FRCPC, FAST

Professor, Department of Medicine
University of Toronto
R. Fraser Elliott Chair, Transplantation
University Health Network
Director, University of Toronto Transplant Institute
Toronto, ON, Canada

razonable

Raymund R. Razonable, MD, FIDSA, FAST

Professor, Medicine
Program Director, Infectious Diseases Fellowship Program
Vice Chair, Division of Infectious Diseases
Mayo Clinic
Rochester, MN

Provider Statement

This activity is provided by RMEI Medical Education, LLC

Supporter Statement

This activity is supported by an independent medical education grant from Takeda.

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources